For: | Kremer M, Hines IN. Natural killer T cells and non-alcoholic fatty liver disease: Fat chews on the immune system. World J Gastroenterol 2008; 14(3): 487-488 [PMID: 18200676 DOI: 10.3748/wjg.14.487] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i3/487.htm |
Number | Citing Articles |
1 |
Maud Lemoine, Lawrence Serfaty. Stéatopathies métaboliques. La Presse Médicale 2012; 41(2): 169 doi: 10.1016/j.lpm.2011.04.006
|
2 |
Nora Bijl, Milka Sokolović, Carlos Vrins, Mirjam Langeveld, Perry D. Moerland, Roelof Ottenhoff, Cindy P. A. A. van Roomen, Nike Claessen, Rolf G. Boot, Jan Aten, Albert K. Groen, Johannes M. F. G. Aerts, Marco van Eijk. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Hepatology 2009; 50(5): 1431 doi: 10.1002/hep.23175
|
3 |
|
4 |
Sonia M. Najjar, Lucia Russo. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Seminars in Immunopathology 2014; 36(1): 55 doi: 10.1007/s00281-013-0407-3
|
5 |
Sha Li, Hor-Yue Tan, Ning Wang, Yigang Feng, Xuanbin Wang, Yibin Feng. Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01328
|
6 |
Tianyu Mao, Rui Yang, Yi Luo, Kang He. Crucial role of T cells in NAFLD-related disease: A review and prospect. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1051076
|
7 |
Azalia Mariel Carranza-Trejo, Vaclav Vetvicka, Lucie Vistejnova, Milena Kralickova, Edgar B. Montufar. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 783 doi: 10.1080/17474124.2021.1887730
|
8 |
Howard C. Masuoka, Naga Chalasani. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences 2013; 1281(1): 106 doi: 10.1111/nyas.12016
|
9 |
Yuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, Volatiana Rakotoarivelo, Sakina Orkhis, Marian Mayhue, Yi-Guang Chen, Marek Rola-Pleszczynski, Alfredo Menendez, Subburaj Ilangumaran, Sheela Ramanathan. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine 2016; 82: 102 doi: 10.1016/j.cyto.2016.01.020
|
10 |
Luca Valenti, Anna Ludovica Fracanzani, Silvia Fargion. The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?. Seminars in Immunopathology 2009; 31(3): 359 doi: 10.1007/s00281-009-0152-9
|
11 |
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.781567
|
12 |
Dan Ye, Jiaofeng Wang, Jiaheng Shi, Yiming Ma, Jie Chen, Xiaona Hu, Zhijun Bao. Genetically predicted metabolites mediate the association between immune cells and metabolic dysfunction-associated steatotic liver disease: a mendelian randomization study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02245-3
|
13 |
Fawzeia H. Abo-Ali, Mohamed Nazmy Farres, Iman H. Shehata. Study of natural killer and natural killer T cells in chronic hepatitis C infection. Egyptian Liver Journal 2011; 1(1): 47 doi: 10.1097/01.ELX.0000397029.18047.78
|
14 |
Coral Zurera-Egea, Aina Teniente-Serra, Daniel Fuster, Eva Martínez-Cáceres, Roberto Muga, Paola Zuluaga. Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease. Clinical and Experimental Medicine 2023; 23(7): 3539 doi: 10.1007/s10238-023-01121-1
|
15 |
Ayako Suzuki, Anna Mae Diehl. Nonalcoholic Steatohepatitis. Annual Review of Medicine 2017; 68(1): 85 doi: 10.1146/annurev-med-051215-031109
|